PubMed

Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease.

Nowilaty SR, Bouhaimed M; Photodynamic Therapy Study Group.

Br J Ophthalmol. 2006 Aug;90(8):982-6. Epub 2006 May 10.PMID: 16687455 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.

Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS, Li KK.

Ophthalmology. 2003 Dec;110(12):2395-402.PMID: 14644724 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

[No authors listed]

Arch Ophthalmol. 1999 Oct;117(10):1329-45. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10532441 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.

Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM; United Kingdom PDT Users Group.

Ophthalmology. 2005 Jul;112(7):1227-31.PMID: 15921757 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.

Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1241-6. Epub 2005 Jul 12.PMID: 16010552 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Verteporfin In Photodynamic Therapy Study Group.

Am J Ophthalmol. 2001 May;131(5):541-60.PMID: 11336929 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.

Saperstein DA, Rosenfeld PJ, Bressler NM, Rosa RH Jr, Sickenberg M, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, Reaves TA; Verteporfin in Ocular Histoplasmosis (VOH) Study Group.

Ophthalmology. 2002 Aug;109(8):1499-505.PMID: 12153802 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV.

Wachtlin J, Stroux A, Wehner A, Heimann H, Foerster MH.

Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):438-45. Epub 2004 Dec 11.PMID: 15672299 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2001 Feb;119(2):198-207.PMID: 11176980 [PubMed - indexed for MEDLINE]Related articles

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

Spaide RF, Sorenson J, Maranan L.

Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong KK.

Br J Ophthalmol. 2004 Oct;88(10):1315-9.PMID: 15377558 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.

Rosenfeld PJ, Saperstein DA, Bressler NM, Reaves TA, Sickenberg M, Rosa RH Jr, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr; Verteporfin in Ocular Histoplasmosis Study Group.

Ophthalmology. 2004 Sep;111(9):1725-33.PMID: 15350329 [PubMed - indexed for MEDLINE]Related articles

Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks.

Arias L, Pujol O, Rubio M, Caminal J.

Graefes Arch Clin Exp Ophthalmol. 2006 Jun;244(6):753-7. Epub 2005 Oct 14.PMID: 16228218 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2002 Nov;120(11):1443-54.PMID: 12427056 [PubMed - indexed for MEDLINE]Related articles

12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.

Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Della Corte M, Rinaldi M, Romano M, Dell'omo R, Costagliola C.

Retina. 2008 Feb;28(2):289-97.PMID: 18301052 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

Verteporfin in Photodynamic Therapy Study Group.

Ophthalmology. 2001 May;108(5):841-52.PMID: 11320011 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.

Farah ME, Costa RA, Muccioli C, Guia TA, Belfort R Jr.

Am J Ophthalmol. 2002 Jul;134(1):137-9.PMID: 12095828 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.

Shaikh S, Ruby AJ, Williams GA.

Am J Ophthalmol. 2003 Jan;135(1):1-6.PMID: 12504689 [PubMed - indexed for MEDLINE]Related articles

Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.

Wachtlin J, Heimann H, Behme T, Foerster MH.

Graefes Arch Clin Exp Ophthalmol. 2003 Nov;241(11):899-906. Epub 2003 Oct 11.PMID: 14556077 [PubMed - indexed for MEDLINE]Related articles